Related Experiment Video

Updated: Jul 19, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Adiponectin and insulin resistance in early- and late-onset pre-eclampsia

R D'Anna1, G Baviera, F Corrado

  • 1Department of Obstetrics and Gynecology, University of Messina, Messina, Italy. rosariodanna@tin.it

BJOG : an International Journal of Obstetrics and Gynaecology
|October 3, 2006
PubMed

Insights

Early and late-onset pre-eclampsia may have different causes, as indicated by distinct first-trimester adiponectin and insulin resistance (HOMA-IR) levels. These markers may help differentiate between these two forms of pre-eclampsia.

Area of Science:

  • Reproductive Endocrinology
  • Metabolic Disorders
  • Maternal-Fetal Medicine

Background:

  • Pre-eclampsia is a serious pregnancy complication.
  • Adiponectin and insulin resistance are implicated in various metabolic conditions.
  • Understanding early- and late-onset pre-eclampsia may reveal different underlying mechanisms.

Purpose of the Study:

  • To investigate the roles of adiponectin and insulin resistance in early- and late-onset pre-eclampsia.
  • To determine if these markers can differentiate between the onset types of pre-eclampsia.

Main Methods:

  • A nested case-control study involving 72 pregnant women.
  • Measurement of plasma adiponectin and homeostasis model assessment of insulin resistance (HOMA-IR) in the first trimester and at delivery.
  • Comparison of pre-eclampsia groups (early- and late-onset) with uncomplicated pregnancies.

Main Results:

  • First-trimester adiponectin levels were lower and HOMA-IR was higher in the overall pre-eclampsia group compared to controls.
  • Late-onset pre-eclampsia showed significantly lower first-trimester adiponectin and higher HOMA-IR compared to early-onset pre-eclampsia and controls.
  • Adiponectin levels at delivery were higher in the pre-eclampsia group than controls.

Conclusions:

  • First-trimester adiponectin and HOMA-IR levels appear to distinguish between early- and late-onset pre-eclampsia.
  • These findings suggest potentially different pathophysiological pathways for early- and late-onset pre-eclampsia.
Abstract

More Related Videos

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...